Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Er Tong Ke Ke Li
- Development stage
- Unknown
- Lead developer
- Yangtze River Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Er Tong Ke Ke Li (儿童咳颗粒) is a traditional Chinese patent medicine (中成药) developed by Yangzijiang Pharmaceutical Group. It is formulated specifically for pediatric use to treat cough, asthma, and bronchitis. The formulation is based on a clinical experience prescription from Beijing Children's Hospital and consists of nine herbal ingredients: Aster tataricus (紫菀), Stemona sessilifolia (百部), Eriobotrya japonica (枇杷叶), Peucedanum praeruptorum (前胡), Glycyrrhiza uralensis (甘草), Prunus armeniaca (苦杏仁), Platycodon grandiflorus (桔梗), Ephedra sinica (麻黄), and Polygonum tinctorium (蓼大青叶). Er Tong Ke Ke Li works by clearing heat, moistening the lungs, promoting the dispersing and descending functions of lung Qi, resolving phlegm, and relieving cough. It is commonly used for children presenting with cough, wheezing, thick yellow sputum, dry throat, sore throat, and acute or chronic bronchitis.
- Brand names
- Hu You护佑
- Other names
- Ertong Ke Ke LiErtongke Keli儿童咳颗粒
Beyond the preview
Go deeper on Er Tong Ke Ke Li.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Er Tong Ke Ke Li.